Canal Capital Management, LLC Illumina, Inc. Transaction History

Canal Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$187.24 - $242.74 $23,966 - $31,070	-128 Reduced 1.74%	7,229 $1.46 Million
Q4 2022 Jan 31, 2023	SELL	$187.24 - $242.74 $613,959 - $795,944	-3,279 Reduced 30.83%	7,357 $1.49 Million
Q3 2022 Oct 24, 2022	BUY	$177.23 - $227.44 $289,416 - $371,409	1,633 Added 18.14%	10,636 $2.03 Million
Q2 2022 Jul 25, 2022	BUY	$181.58 - $368.0 $466,115 - $944,656	2,567 Added 39.89%	9,003 $1.66 Million
Q1 2022 Apr 20, 2022	BUY	$303.87 - $423.8 $216,963 - $302,593	714 Added 12.48%	6,436 $2.25 Million
Q4 2021 Jan 27, 2022	BUY	$347.28 - $421.83 $273,309 - $331,980	787 Added 15.95%	5,722 $2.18 Million
Q3 2021 Oct 14, 2021	BUY	$405.61 - $524.84 $461,584 - $597,267	1,138 Added 29.97%	4,935 $2 Million
Q2 2021 Jul 14, 2021	BUY	$372.84 - $481.5 $1.07 Million - $1.39 Million	2,878 Added 313.17%	3,797 $1.8 Million
Q1 2021 Apr 20, 2021	BUY	$361.28 - $504.76 $24,567 - $34,323	68 Added 7.99%	919 $353,000
Q4 2020 Jan 27, 2021	BUY	$292.7 - $370.96 $249,087 - $315,686	851 New	851 $315,000

900

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $20.6B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Canal Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Canal Capital Management, LLC with notifications on news.